Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Depression symptoms increase risk for heart disease, stroke in middle-aged and older adults

Depression and its symptoms increase as people age, and have been linked to heart disease and stroke in both middle-aged and older adults. But whether depression and its symptoms are risk factors for these two dangerous conditions has been unclear.

2 Feb 2016

Lilly receives FDA approval for Humulin R U-500 KwikPen

The U.S. Food and Drug Administration has approved Eli Lilly and Company's Humulin R U-500 KwikPen(insulin human injection) 500 units/mL, a pre-filled device containing Humulin R U-500, a highly concentrated formulation of insulin.

21 Jan 2016

Short bursts of intensive exercise could be more effective in preventing Type 2 diabetes

Short bursts of intensive exercise provide a more "time-efficient" and realistic way of preventing, delaying and managing Type 2 diabetes and also losing weight, a study has found.

20 Jan 2016

Coordinated care approach to diabetes self-management benefits underserved adult populations

Even in communities with barriers to health care, exercise opportunities and healthy food, residents with diabetes saw improved health outcomes when they participated in programs that took a coordinated care approach to diabetes self-management.

12 Jan 2016

Sugary foods may affect recovery from heart attack

Scientists at the University of Leicester have demonstrated for the first time the mechanism by which the level of sugar in your blood can affect the contraction of blood vessels, with potentially dangerous effects on the heart and blood pressure.

8 Jan 2016

Insulin-producing cells' mitochondria may represent useful therapeutic target in type 2 diabetes

Factors in the blood from calorie-restricted rats can modify energy-producing mitochondria within the insulin-producing cells that regulate blood sugar levels, new research shows. This has a positive impact on glucose-stimulated insulin secretion and protects cells from fatty acid and glucose toxicity.

7 Jan 2016

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Researchers have identified a mechanism that allows cancer cells to respond and grow rapidly when levels of sugar in the blood rise. This may help to explain why people who develop conditions in which they have chronically high sugar levels in their blood, such as obesity, also have an increased risk of developing certain types of cancer.

6 Jan 2016

UVA-developed artificial pancreas system to undergo final testing in two clinical trials

A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning in early 2016.

5 Jan 2016

Researchers to undertake long-term clinical trial of artificial pancreas system for type 1 diabetes patients

Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the so-called artificial pancreas system performs in patients as hoped, it could lead to commercial trials and eventual regulatory approval in the United States and abroad.

5 Jan 2016

UAB study to examine social support, intuitive eating impact on older African-American men with diabetes

University of Alabama at Birmingham School of Nursing Assistant Professor Loretta T. Lee, Ph.D., has received a 2015 Deep South Resource Center for Minority Aging pilot grant award to examine the association of social support and intuitive eating with glycemic control in older African-American men with diagnosed type 2 diabetes.

30 Dec 2015

Study finds gaps in consumer understanding of their health information

According to HealthMine's research, conducted with more than 6,000 consumers enrolled in health plans in 2015, 53% of consumers said it's not easy to understand their health information, or what they need to do to maintain or improve their health. Yet, wellness programs have the potential to discover sick and at-risk members in the population; 46% of consumers with a chronic condition who were surveyed said they discovered their illness through a wellness program.

28 Dec 2015

Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide

Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.

24 Dec 2015

One of every three deaths in the U.S. linked to cardiovascular diseases

One of every three deaths in the U.S. in 2013 were from heart disease, stroke and other cardiovascular diseases, while heart disease and stroke were the No. 1 and No. 2 killers worldwide, according to American Heart Association's 2016 Heart Disease and Stroke Statistics Update.

17 Dec 2015

Oxford research programmes to explore link between metabolism, inflammation in metabolic diseases

Two innovative Oxford research programmes will explore the relationship between metabolism and inflammation in metabolic diseases. Obesity, insulin resistance, type 2 diabetes (T2D) and associated cardiovascular disease (CVD) -- all metabolic diseases -- are an epidemic global health problem.

17 Dec 2015

Standing up or walking for just five minutes could help prevent Type 2 diabetes

Women who have an inactive daily routine and are at high risk of Type 2 diabetes can help prevent the condition by regularly standing up or walking for five minutes at a time, a new study has found.

17 Dec 2015

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

17 Dec 2015

Study highlights strong need for weight management before menopause

At midlife, overweight and obesity, lack of exercise, less education, and low income put women at much higher risk of having metabolic syndrome, the cluster of conditions predisposes people to diabetes and heart disease, shows a large study published today in Menopause, the journal of The North American Menopause Society.

16 Dec 2015

Major clinical trial launched to test ways to slow or halt mental decline in seniors

Some decline in memory and cognitive function is a normal part of aging, but what if it could be prevented? Researchers at University of California, San Diego School of Medicine and Washington University in St. Louis have launched a major clinical trial to investigate whether mental decline in seniors can be slowed or halted through exercise and other health-related interventions.

16 Dec 2015

Researchers test new concept in type 2 diabetes patients going into remission

Remission is well-known as the goal in cancer treatment but scientists are discovering it's also an exciting possibility for those with type 2 diabetes.

16 Dec 2015

Innovative Phase II trial evaluates effectiveness of diabetes medication for lymphoma

Cancer, it could be said, grows like a weed: rapidly, invasively, and with devastating impact on the place it infests. Also like a weed, cancer can't grow on its own — it needs nourishment, which it drains from the human body, just as weeds take nutrients in the soil away from other plants.

13 Dec 2015

Blood Sugar News and Research

Further Reading

Depression symptoms increase risk for heart disease, stroke in middle-aged and older adults

Lilly receives FDA approval for Humulin R U-500 KwikPen

Short bursts of intensive exercise could be more effective in preventing Type 2 diabetes

Coordinated care approach to diabetes self-management benefits underserved adult populations

Sugary foods may affect recovery from heart attack

Insulin-producing cells' mitochondria may represent useful therapeutic target in type 2 diabetes

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

UVA-developed artificial pancreas system to undergo final testing in two clinical trials

Researchers to undertake long-term clinical trial of artificial pancreas system for type 1 diabetes patients

UAB study to examine social support, intuitive eating impact on older African-American men with diabetes

Study finds gaps in consumer understanding of their health information

Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide

One of every three deaths in the U.S. linked to cardiovascular diseases

Oxford research programmes to explore link between metabolism, inflammation in metabolic diseases

Standing up or walking for just five minutes could help prevent Type 2 diabetes

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

Study highlights strong need for weight management before menopause

Major clinical trial launched to test ways to slow or halt mental decline in seniors

Researchers test new concept in type 2 diabetes patients going into remission

Innovative Phase II trial evaluates effectiveness of diabetes medication for lymphoma

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News